Key regions: United States, South Korea, Japan, Canada, India
The Digestive & Intestinal Remedies (Pharmacies) market in EU-27 is experiencing steady growth due to customer preferences for natural and holistic remedies, as well as an increase in gastrointestinal disorders and digestive health concerns.
Customer preferences: Customers in the EU-27 region are increasingly seeking natural and holistic remedies for digestive and intestinal issues. This shift in preferences can be attributed to a growing awareness of the potential side effects of traditional pharmaceutical products, as well as a desire for more sustainable and environmentally friendly options. As a result, there has been an increased demand for herbal and plant-based remedies, probiotics, and dietary supplements that promote digestive health.
Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in the EU-27 region is the rise in gastrointestinal disorders and digestive health concerns. Factors such as unhealthy diets, stress, and sedentary lifestyles have contributed to an increase in conditions like irritable bowel syndrome, acid reflux, and constipation. This has led to a greater demand for over-the-counter remedies that provide relief from these symptoms. Additionally, the aging population in many EU-27 countries has also contributed to the growth of the market, as older individuals are more prone to digestive issues.
Local special circumstances: Each country within the EU-27 region has its own unique set of circumstances that influence the Digestive & Intestinal Remedies market. For example, countries with a strong tradition of herbal medicine, such as Germany and Austria, have seen a higher demand for natural remedies compared to countries where traditional pharmaceuticals are more prevalent. Additionally, cultural factors and dietary habits can also play a role in shaping customer preferences and market trends. For instance, countries with a diet rich in spicy foods, like Spain and Italy, may have a higher demand for remedies that target heartburn and indigestion.
Underlying macroeconomic factors: The growth of the Digestive & Intestinal Remedies market in the EU-27 region is also influenced by underlying macroeconomic factors. For instance, rising healthcare costs and the increasing burden on public healthcare systems have led individuals to seek self-care options for minor ailments. This has contributed to the growth of the over-the-counter market, as consumers are more willing to purchase remedies without a prescription. Additionally, the increasing availability and accessibility of these products through online platforms and e-commerce have also contributed to market growth. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in EU-27 is experiencing steady growth due to customer preferences for natural and holistic remedies, an increase in gastrointestinal disorders and digestive health concerns, as well as underlying macroeconomic factors such as rising healthcare costs and the increasing availability of over-the-counter products.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
